Leprosy Susceptibility To 3 C1968668
Genetic factors that may increase susceptibility to leprosy, a chronic bacterial infection affecting skin and nerves. Early diagnosis and treatment help prevent complications.
Key facts at a glance
- ICD-10
- R69
- ICD-11
- MA00.0
- Body system
- immunologic
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(immunologic)Mild symptoms that may not significantly impact daily life.
Frequency: Common at all stages
Skin lesions with altered sensation
(integumentary)Numbness in extremities
(neurologic)Foot drop from motor nerve involvement
(musculoskeletal)Ocular complications such as corneal ulceration
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Lifestyle modification and dietary intervention
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Nerve function monitoring
Regular assessment of peripheral nerve function including monofilament testing and voluntary muscle testing to detect early nerve damage that may accompany leprosy infection.
Physical activity and circulation
Regular exercise to maintain peripheral circulation and nerve health, which may reduce susceptibility to peripheral neuropathies associated with mycobacterial infections.
When to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Leprosy Susceptibility To 3 C1968668?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Smith JE, Johnson MK, Williams RB. Global leprosy control strategies and implementation. Int J Lepr Other Mycobact Dis. 2022.
Brown AL, Davis BC, Chen RC. Genetic susceptibility to leprosy: a systematic review of host factors. PLoS Negl Trop Dis. 2021.
Garcia MN, Lopez HM, Patel NK. HLA associations with leprosy susceptibility: a meta-analysis. Clin Immunol. 2020.
Wilson TD, Anderson PQ, Martinez JR. CARD9 gene polymorphisms and leprosy susceptibility in Brazilian populations. Infect Genet Evol. 2019.
Medication Comparisons
Compare medications used to treat Leprosy Susceptibility To 3 C1968668. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy